Advanced Biomedical Technologies Inc.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020): $123.6K
Net Income/Loss (FY2020): -$672.0K
Total Assets (FY2020): $469.2K
Total Equity (FY2020): -$7.4M
Cash Flows from Operating Activities (FY2020): $646.7K

Source: Advanced Biomedical Technologies Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Advanced Biomedical Technologies Inc.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020): $123.6K
Net Income/Loss (FY2020): -$672.0K
Total Assets (FY2020): $469.2K
Total Equity (FY2020): -$7.4M
Cash Flows from Operating Activities (FY2020): $646.7K

Source: Advanced Biomedical Technologies Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.